|
|
 | | | |
- close
- close
- close
- close
Bioniche Life Sciences (BNC) |
QUOTE AND NEWS
PR Newswire
May 9
Comment
- sales of Animal Health products 10% ahead of Fiscal 2011 on a year-to-date basis - (all figures are in Canadian dollars unless otherwise noted) BELLEVILLE, ON, May 9, 2012 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a
PR Newswire
May 1
Comment
-one to launch as early as July of 2012- BELLEVILLE, ON, May 1, 2012 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it is commercializing
PR Newswire
Apr 16
Comment
-one in Australia and one in Canada- BELLEVILLE, ON, April 16, 2012 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it is sponsoring two
PR Newswire
Apr 10
Comment
BELLEVILLE, ON, April 10, 2012 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today announced that it has closed a US$20 million financing from investment
PR Newswire
Mar 22
Comment
- Bioniche appointed exclusive Australian distribution of four products - BELLEVILLE, ON, March 22, 2012 /PRNewswire/ - Bioniche Life Sciences Inc. (TSX: BNC) (ASX: BNC), a research-based, technology-driven Canadian biopharmaceutical company, today
Canadian Business
Feb 10
Comment
BELLEVILLE, Ont. - Sales at Bioniche Life Sciences Inc. (TSX:BNC) slipped in its fiscal 2011 second quarter, leading to a decline in revenue and
Canadian Business
Dec 6
Comment
BELLEVILLE, Ont. - Canadian biopharmaceutical company Bioniche Life Sciences Inc. (TSX:BNC) announced an agreement Monday that will see the Angus
Canadian Business
Nov 10
Comment
BELLEVILLE, Ont. - A big improvement in animal health product sales helped Bioniche Life Sciences Inc. (TSX:BNC) cut its first-quarter loss almost
Canadian Business
Sep 10
Comment
BELLEVILLE, Ont. - Bioniche Life Sciences Inc. (TSX: BNC), an animal health and bladder cancer drug developer, reports its net loss for the 2010
Canadian Business
May 12
Comment
BELLEVILLE, Ont. - Bioniche Life Sciences Inc. (TSX:BNC), a research-based biopharmaceutical company, reports a fiscal third quarter profit of
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS
 |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
